Drug Profile
Naproxen/phosphatidylcholine
Alternative Names: PL-3100Latest Information Update: 29 May 2015
Price :
$50
*
At a glance
- Originator PLx Pharma
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Arthritis
Most Recent Events
- 09 Jul 2010 Phase-II clinical trials in Arthritis (in volunteers) in USA (PO)